These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

100 related items for PubMed ID: 3079078

  • 1. Antiidiotypic antibody activity in patients receiving donor specific transfusions and cyclosporine A.
    Stewart KN, Power DA, Hills AN, Catto GR.
    Transplant Proc; 1987 Feb; 19(1 Pt 3):2262-3. PubMed ID: 3079078
    [No Abstract] [Full Text] [Related]

  • 2. Antiidiotypic activity and sensitization after donor-specific transfusion (DST) given with and without cyclosporin A (CsA).
    Hillis AN, MacLeod AM, al-Muzairai IA, Innes A, Stewart KN, Power DA, Bone MJ, Sells RA, Catto GR.
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1820-1. PubMed ID: 2652591
    [No Abstract] [Full Text] [Related]

  • 3. Anti-idiotypic autoantibodies after donor-specific blood transfusions.
    Toma H, Hayasaka Y, Yasuo M, Takahashi K, Teraoka S, Ota K.
    Transplant Proc; 1987 Feb; 19(1 Pt 1):755-7. PubMed ID: 3274864
    [No Abstract] [Full Text] [Related]

  • 4. Anti-idiotypic activity in cytotoxic sera from highly sensitised patients (HSP) given cyclosporin A and blood transfusion from a specific donor (ST).
    al-Muzairai IA, MacLeod AM, Cochrane S, Jones MC, Propper D, Catto GR.
    Transplant Proc; 1989 Feb; 21(1 Pt 1):748-9. PubMed ID: 2650254
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Donor-specific T cell alloreactivity in relation to 1 haplotype-mismatched blood transfusion prior to living-donor renal transplantation.
    Bakran A, Taylor GM, Read I, Fergusson W, Johnson RW.
    Transplant Proc; 1987 Feb; 19(1 Pt 1):748-9. PubMed ID: 2978929
    [No Abstract] [Full Text] [Related]

  • 7. Recipient sensitization against donor cells in pre- and/or posttransplantation sera is inversely correlated with graft survival.
    Sumitran S, Forsberg I, Lindholm A, Lundgren G, Möller E.
    Transplant Proc; 1987 Feb; 19(1 Pt 2):1566-7. PubMed ID: 3274384
    [No Abstract] [Full Text] [Related]

  • 8. Three year experience of donor specific transfusion and concomitant cyclosporine A.
    Hillis AN, Duguid J, Evans CM, Bone JM, Sells RA.
    Transplant Proc; 1987 Feb; 19(1 Pt 3):2248-9. PubMed ID: 2978890
    [No Abstract] [Full Text] [Related]

  • 9. Results of transplantation with remote-positive proximate-negative T cell antiglobulin crossmatches.
    Hodge E, Novick A, Lewis R, Steinmuller D, Streem S, Cunningham R, Braun W, Zachary A, Protiva D.
    Transplant Proc; 1987 Feb; 19(1 Pt 1):789-91. PubMed ID: 3274874
    [No Abstract] [Full Text] [Related]

  • 10. Concomitant low-dose cyclosporine and OKT3 therapy for renal transplant rejection.
    Hricik DE, Zarconi J, Schulak JA.
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1755-7. PubMed ID: 2652574
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. A randomized study of buffy coat transfusions in cadaveric renal transplantation.
    Norman DJ, Fletcher L, Barry J.
    Transplant Proc; 1987 Feb; 19(1 Pt 3):1967-70. PubMed ID: 3547901
    [No Abstract] [Full Text] [Related]

  • 14. Clinical relevance of pretransplant flow cytometric crossmatches with T and B lymphocytes in kidney transplantation.
    Berteli AJ, Daniel V, Pomer S, Opelz G.
    Transplant Proc; 1990 Aug; 22(4):1895-6. PubMed ID: 2389477
    [No Abstract] [Full Text] [Related]

  • 15. Renal allograft survival in highly sensitized patients treated with cyclosporine.
    Doran M, Coppage M, Ruth J, Fish J, Winsett O, Vaidya S.
    Transplant Proc; 1987 Feb; 19(1 Pt 3):1988. PubMed ID: 3274458
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Role of HLA matching and pretransplant blood transfusions in cyclosporine-treated recipients of cadaveric renal allografts: 2- to 3-year results.
    Lundgren G, Albrechtsen D, Brynger H, Flatmark A, Frödin L, Gäbel H, Lindholm A, Maurer W, Möller E, Persson H.
    Transplant Proc; 1987 Oct; 19(5):3614-8. PubMed ID: 3313870
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Development of anti-idiotypic antibodies to HLA antigens in human hepatic allograft tolerance.
    Mohanakumar T, Hoover SK, Rhodes C, Mendez-Picon G, Flye MW, Lee HM.
    Transplant Proc; 1987 Feb; 19(1 Pt 3):2437-9. PubMed ID: 3079084
    [No Abstract] [Full Text] [Related]

  • 20. Sustained high panel reactive antibody levels in highly sensitized patients: significance of continued transfusions.
    Deierhoi MH, Shroyer TW, Hudson SL, Barger BO, Barber WH, Curtis JJ, Julian BA, Diethelm AG.
    Transplant Proc; 1989 Feb; 21(1 Pt 1):771-2. PubMed ID: 2650266
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.